Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia. [electronic resource]
Producer: 20140408Description: 712-6 p. digitalISSN:- 1545-5017
- Adolescent
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow Transplantation
- Busulfan -- administration & dosage
- Child
- Child, Preschool
- Combined Modality Therapy
- Cytarabine -- administration & dosage
- Female
- Follow-Up Studies
- Graft vs Host Disease -- mortality
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Infant
- Infant, Newborn
- Leukemia, Myeloid, Acute -- mortality
- Male
- Melphalan -- administration & dosage
- Neoplasm Recurrence, Local -- mortality
- Postoperative Complications
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- mortality
- Prognosis
- Remission Induction
- Survival Rate
- Transplantation Conditioning
- Transplantation, Homologous
- Vidarabine -- administration & dosage
- Whole-Body Irradiation
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.